{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T04:33:45Z","timestamp":1747802025375,"version":"3.41.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Subsidy Funds for Medical Double-high Project of Fujian Province","award":["ETK2024007"],"award-info":[{"award-number":["ETK2024007"]}]},{"name":"Fujian Children's Hospital Cultivation Project","award":["YP202401"],"award-info":[{"award-number":["YP202401"]}]},{"name":"Joint Funds for the Innovation of Science and Technology, Fujian Province","award":["2024Y9554"],"award-info":[{"award-number":["2024Y9554"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-02735-5","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T19:20:44Z","timestamp":1747768844000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mendelian randomization analysis reveals the causal relationship between immune cells and leukemia"],"prefix":"10.1007","volume":"16","author":[{"given":"Yaobin","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shenghong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianyuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"issue":"1","key":"2735_CR1","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1186\/s12889-023-16226-1","volume":"23","author":"K Lin","year":"2023","unstructured":"Lin K, Jia H, Cao M, et al. Epidemiological characteristics of leukemia in China, 2005\u20132017: a log-linear regression and age-period-cohort analysis. BMC Public Health. 2023;23(1):1647. https:\/\/doi.org\/10.1186\/s12889-023-16226-1.","journal-title":"BMC Public Health"},{"key":"2735_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-024-02217-7","author":"A Perzolli","year":"2024","unstructured":"Perzolli A, Koedijk JB, Zwaan CM, et al. Targeting the innate immune system in pediatric and adult AML. Leukemia. 2024. https:\/\/doi.org\/10.1038\/s41375-024-02217-7.","journal-title":"Leukemia"},{"issue":"4","key":"2735_CR3","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.3324\/haematol.2023.282915","volume":"109","author":"Y Kaito","year":"2024","unstructured":"Kaito Y, Sugimoto E, Nakamura F, et al. Immune checkpoint molecule DNAM-1\/CD112 axis is a novel target for natural killer-cell therapy in acute myeloid leukemia. Haematologica. 2024;109(4):1107\u201320. https:\/\/doi.org\/10.3324\/haematol.2023.282915.","journal-title":"Haematologica"},{"issue":"1","key":"2735_CR4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12964-023-01428-2","volume":"22","author":"A Barshidi","year":"2024","unstructured":"Barshidi A, Ardeshiri K, Ebrahimi F, et al. The role of exhausted natural killer cells in the immunopathogenesis and treatment of leukemia. Cell Commun Signal. 2024;22(1):59. https:\/\/doi.org\/10.1186\/s12964-023-01428-2.","journal-title":"Cell Commun Signal"},{"key":"2735_CR5","doi-asserted-by":"publisher","DOI":"10.1172\/jci159579","author":"S Rutella","year":"2022","unstructured":"Rutella S, Vadakekolathu J, Mazziotta F, et al. Immune dysfunction signatures predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemia. J Clin Investig. 2022. https:\/\/doi.org\/10.1172\/jci159579.","journal-title":"J Clin Investig"},{"key":"2735_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cells11040661","author":"MK Zarobkiewicz","year":"2022","unstructured":"Zarobkiewicz MK, Bojarska-Junak AA. The mysterious actor-\u03b3\u03b4 T lymphocytes in chronic lymphocytic leukaemia (CLL). Cells. 2022. https:\/\/doi.org\/10.3390\/cells11040661.","journal-title":"Cells"},{"issue":"4","key":"2735_CR7","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/leu.2015.327","volume":"30","author":"RH Rouce","year":"2016","unstructured":"Rouce RH, Shaim H, Sekine T, et al. The TGF-\u03b2\/SMAD pathway is an important mechanism for NK cell immune evasion in childhood B-acute lymphoblastic leukemia. Leukemia. 2016;30(4):800\u201311. https:\/\/doi.org\/10.1038\/leu.2015.327.","journal-title":"Leukemia"},{"issue":"1","key":"2735_CR8","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1093\/ije\/dyx275","volume":"47","author":"S Greenland","year":"2018","unstructured":"Greenland S. An introduction to instrumental variables for epidemiologists. Int J Epidemiol. 2018;47(1):358. https:\/\/doi.org\/10.1093\/ije\/dyx275.","journal-title":"Int J Epidemiol"},{"key":"2735_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k601","volume":"362","author":"NM Davies","year":"2018","unstructured":"Davies NM, Holmes MV, Davey SG. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ (Clinical research ed). 2018;362: k601. https:\/\/doi.org\/10.1136\/bmj.k601.","journal-title":"BMJ (Clinical research ed)"},{"issue":"10","key":"2735_CR10","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","volume":"52","author":"V Orr\u00f9","year":"2020","unstructured":"Orr\u00f9 V, Steri M, Sidore C, et al. Complex genetic signatures in immune cells underlie autoimmunity and inform therapy. Nat Genet. 2020;52(10):1036\u201345. https:\/\/doi.org\/10.1038\/s41588-020-0684-4.","journal-title":"Nat Genet"},{"issue":"7944","key":"2735_CR11","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki MI, Karjalainen J, Palta P, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613(7944):508\u201318. https:\/\/doi.org\/10.1038\/s41586-022-05473-8.","journal-title":"Nature"},{"key":"2735_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clinical research ed). 2021;372: n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ (Clinical research ed)"},{"issue":"1","key":"2735_CR13","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41467-020-14389-8","volume":"11","author":"N Papadimitriou","year":"2020","unstructured":"Papadimitriou N, Dimou N, Tsilidis KK, et al. Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis. Nat Commun. 2020;11(1):597. https:\/\/doi.org\/10.1038\/s41467-020-14389-8.","journal-title":"Nat Commun"},{"issue":"1","key":"2735_CR14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12974-023-02999-0","volume":"21","author":"D Ji","year":"2024","unstructured":"Ji D, Chen WZ, Zhang L, et al. Gut microbiota, circulating cytokines and dementia: a Mendelian randomization study. J Neuroinflammation. 2024;21(1):2. https:\/\/doi.org\/10.1186\/s12974-023-02999-0.","journal-title":"J Neuroinflammation"},{"issue":"16","key":"2735_CR15","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1158\/0008-5472.Can-20-0985","volume":"80","author":"SH Lin","year":"2020","unstructured":"Lin SH, Brown DW, Machiela MJ. LDtrait: an online tool for identifying published phenotype associations in linkage disequilibrium. Can Res. 2020;80(16):3443\u20136. https:\/\/doi.org\/10.1158\/0008-5472.Can-20-0985.","journal-title":"Can Res"},{"key":"2735_CR16","doi-asserted-by":"publisher","first-page":"1440941","DOI":"10.3389\/fendo.2024.1440941","volume":"15","author":"L Gao","year":"2024","unstructured":"Gao L, Li W, Song Q, et al. The genetic link between thyroid dysfunction and alopecia areata: a bidirectional two-sample Mendelian randomization study. Front Endocrinol. 2024;15:1440941. https:\/\/doi.org\/10.3389\/fendo.2024.1440941.","journal-title":"Front Endocrinol"},{"issue":"1","key":"2735_CR17","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/bjc.2017.360","volume":"118","author":"J Hwee","year":"2018","unstructured":"Hwee J, Tait C, Sung L, et al. A systematic review and meta-analysis of the association between childhood infections and the risk of childhood acute lymphoblastic leukaemia. Br J Cancer. 2018;118(1):127\u201337. https:\/\/doi.org\/10.1038\/bjc.2017.360.","journal-title":"Br J Cancer"},{"key":"2735_CR18","doi-asserted-by":"publisher","first-page":"1185787","DOI":"10.3389\/fmicb.2023.1185787","volume":"14","author":"P Guevara-Ram\u00edrez","year":"2023","unstructured":"Guevara-Ram\u00edrez P, Cadena-Ullauri S, Paz-Cruz E, et al. Role of the gut microbiota in hematologic cancer. Front Microbiol. 2023;14:1185787. https:\/\/doi.org\/10.3389\/fmicb.2023.1185787.","journal-title":"Front Microbiol"},{"issue":"1","key":"2735_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ijheh.2018.08.004","volume":"222","author":"G Van Maele-Fabry","year":"2019","unstructured":"Van Maele-Fabry G, Gamet-Payrastre L, Lison D. Household exposure to pesticides and risk of leukemia in children and adolescents: updated systematic review and meta-analysis. Int J Hyg Environ Health. 2019;222(1):49\u201367. https:\/\/doi.org\/10.1016\/j.ijheh.2018.08.004.","journal-title":"Int J Hyg Environ Health"},{"key":"2735_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2022.101017","volume":"58","author":"RP Gale","year":"2023","unstructured":"Gale RP. Radiation and leukaemia: which leukaemias and what doses? Blood Rev. 2023;58: 101017. https:\/\/doi.org\/10.1016\/j.blre.2022.101017.","journal-title":"Blood Rev"},{"issue":"15","key":"2735_CR21","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1182\/blood-2012-08-448068","volume":"121","author":"LM Morton","year":"2013","unstructured":"Morton LM, Dores GM, Tucker MA, et al. Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975\u20132008. Blood. 2013;121(15):2996\u20133004. https:\/\/doi.org\/10.1182\/blood-2012-08-448068.","journal-title":"Blood"},{"issue":"9945","key":"2735_CR22","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/s0140-6736(14)60892-8","volume":"384","author":"K Bhaskaran","year":"2014","unstructured":"Bhaskaran K, Douglas I, Forbes H, et al. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5\u00b724 million UK adults. Lancet (London, England). 2014;384(9945):755\u201365. https:\/\/doi.org\/10.1016\/s0140-6736(14)60892-8.","journal-title":"Lancet (London, England)"},{"issue":"6","key":"2735_CR23","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1093\/ije\/dyx034","volume":"46","author":"OO Yavorska","year":"2017","unstructured":"Yavorska OO, Burgess S. MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data. Int J Epidemiol. 2017;46(6):1734\u20139. https:\/\/doi.org\/10.1093\/ije\/dyx034.","journal-title":"Int J Epidemiol"},{"key":"2735_CR24","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.3389\/fimmu.2019.01068","volume":"10","author":"A Ivetic","year":"2019","unstructured":"Ivetic A, Hoskins Green HL, Hart SJ. L-selectin: a major regulator of leukocyte adhesion, migration and signaling. Front Immunol. 2019;10:1068. https:\/\/doi.org\/10.3389\/fimmu.2019.01068.","journal-title":"Front Immunol"},{"issue":"10","key":"2735_CR25","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s00262-017-2022-y","volume":"66","author":"Y D\u00edaz-Rodr\u00edguez","year":"2017","unstructured":"D\u00edaz-Rodr\u00edguez Y, Cordeiro P, Belounis A, et al. In vitro differentiated plasmacytoid dendritic cells as a tool to induce anti-leukemia activity of natural killer cells. Cancer Immunol Immunother CII. 2017;66(10):1307\u201320. https:\/\/doi.org\/10.1007\/s00262-017-2022-y.","journal-title":"Cancer Immunol Immunother CII"},{"issue":"10","key":"2735_CR26","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1038\/leu.2014.105","volume":"28","author":"D Saulep-Easton","year":"2014","unstructured":"Saulep-Easton D, Vincent FB, Le Page M, et al. Cytokine-driven loss of plasmacytoid dendritic cell function in chronic lymphocytic leukemia. Leukemia. 2014;28(10):2005\u201315. https:\/\/doi.org\/10.1038\/leu.2014.105.","journal-title":"Leukemia"},{"issue":"8","key":"2735_CR27","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/nri3865","volume":"15","author":"M Swiecki","year":"2015","unstructured":"Swiecki M, Colonna M. The multifaceted biology of plasmacytoid dendritic cells. Nat Rev Immunol. 2015;15(8):471\u201385. https:\/\/doi.org\/10.1038\/nri3865.","journal-title":"Nat Rev Immunol"},{"key":"2735_CR28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.semcdb.2018.02.014","volume":"86","author":"S Alculumbre","year":"2019","unstructured":"Alculumbre S, Raieli S, Hoffmann C, et al. Plasmacytoid pre-dendritic cells (pDC): from molecular pathways to function and disease association. Semin Cell Dev Biol. 2019;86:24\u201335. https:\/\/doi.org\/10.1016\/j.semcdb.2018.02.014.","journal-title":"Semin Cell Dev Biol"},{"issue":"19","key":"2735_CR29","doi-asserted-by":"publisher","first-page":"7007","DOI":"10.1002\/cam4.3360","volume":"9","author":"SY Hyun","year":"2020","unstructured":"Hyun SY, Na EJ, Jang JE, et al. Immunosuppressive role of CD11b(+) CD33(+) HLA-DR(-) myeloid-derived suppressor cells-like blast subpopulation in acute myeloid leukemia. Cancer Med. 2020;9(19):7007\u201317. https:\/\/doi.org\/10.1002\/cam4.3360.","journal-title":"Cancer Med"},{"key":"2735_CR30","doi-asserted-by":"publisher","first-page":"1078118","DOI":"10.3389\/fimmu.2023.1078118","volume":"14","author":"D Yao","year":"2023","unstructured":"Yao D, Lai J, Lu Y, et al. Comprehensive analysis of the immune pattern of T cell subsets in chronic myeloid leukemia before and after TKI treatment. Front Immunol. 2023;14:1078118. https:\/\/doi.org\/10.3389\/fimmu.2023.1078118.","journal-title":"Front Immunol"},{"issue":"1","key":"2735_CR31","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13045-018-0636-y","volume":"11","author":"L Xu","year":"2018","unstructured":"Xu L, Yao D, Tan J, et al. Memory T cells skew toward terminal differentiation in the CD8+ T cell population in patients with acute myeloid leukemia. J Hematol Oncol. 2018;11(1):93. https:\/\/doi.org\/10.1186\/s13045-018-0636-y.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"2735_CR32","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41408-025-01277-x","volume":"15","author":"SA Beer","year":"2025","unstructured":"Beer SA, Went M, Mills C, et al. Mendelian randomization of immune cell phenotypes to discover potential drug targets for B-cell malignancy. Blood Cancer J. 2025;15(1):62. https:\/\/doi.org\/10.1038\/s41408-025-01277-x.","journal-title":"Blood Cancer J"},{"key":"2735_CR33","doi-asserted-by":"publisher","first-page":"1511824","DOI":"10.3389\/fimmu.2024.1511824","volume":"15","author":"M Shan","year":"2024","unstructured":"Shan M, Xu L, Yang W, et al. Identification of hub genes and immune-related pathways in acute myeloid leukemia: insights from bioinformatics and experimental validation. Front Immunol. 2024;15:1511824. https:\/\/doi.org\/10.3389\/fimmu.2024.1511824.","journal-title":"Front Immunol"},{"key":"2735_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2024.107621","volume":"148","author":"S Qian","year":"2025","unstructured":"Qian S, Gong J, Shen X, et al. Causal role of genetically predicted 731 immune cell phenotypes in chronic lymphatic leukemia: a bidirectional Mendelian randomization study. Leuk Res. 2025;148: 107621. https:\/\/doi.org\/10.1016\/j.leukres.2024.107621.","journal-title":"Leuk Res"},{"issue":"1","key":"2735_CR35","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s12672-024-01565-1","volume":"15","author":"F Yu","year":"2024","unstructured":"Yu F, Jiang H, Gu Y. Causal relationship between immune cells and acute myeloid leukemia: a two-sample Mendelian randomization study. Discov Oncol. 2024;15(1):675. https:\/\/doi.org\/10.1007\/s12672-024-01565-1.","journal-title":"Discov Oncol"},{"key":"2735_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113927","volume":"146","author":"K Wu","year":"2025","unstructured":"Wu K, Xu X, Wei W, et al. c-JUN interacts with HDAC1 as a potential combinatorial therapeutic target in acute myeloid leukemia. Int Immunopharmacol. 2025;146: 113927. https:\/\/doi.org\/10.1016\/j.intimp.2024.113927.","journal-title":"Int Immunopharmacol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02735-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-02735-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02735-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T19:20:45Z","timestamp":1747768845000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-02735-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2735"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-02735-5","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"4 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Since the GWAS datas public, the approval of the ethics committee is not required. The GWAS datas has hidden the patient's identity information, so the patient's informed consent is not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"836"}}